Matches in Wikidata for { <http://www.wikidata.org/entity/Q83930154> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q83930154 description "article scientifique publié en 2006" @default.
- Q83930154 description "artículu científicu espublizáu en xunu de 2006" @default.
- Q83930154 description "scientific article published on 05 June 2006" @default.
- Q83930154 description "wetenschappelijk artikel" @default.
- Q83930154 description "наукова стаття, опублікована в червні 2006" @default.
- Q83930154 name "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 name "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 type Item @default.
- Q83930154 label "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 label "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 prefLabel "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 prefLabel "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 P1433 Q83930154-641A1BF3-150A-469B-BD2F-81C598AC5646 @default.
- Q83930154 P1476 Q83930154-3DAA7CE3-A984-469D-8C50-35DA3B8EF392 @default.
- Q83930154 P2093 Q83930154-1E1B8612-0848-4607-BA63-46C444C3E54F @default.
- Q83930154 P2093 Q83930154-231FB3A9-BC85-4E4B-A43B-1AE378080A09 @default.
- Q83930154 P2093 Q83930154-56FD452A-C5BC-4F4B-B624-D655B0A93802 @default.
- Q83930154 P2093 Q83930154-7AF79009-F9AA-4B46-95F3-589EB198529A @default.
- Q83930154 P2093 Q83930154-7CDAE539-CF3D-4762-BA49-436AF89195D5 @default.
- Q83930154 P2093 Q83930154-87EFA973-268A-423C-BFEE-00788DF5742B @default.
- Q83930154 P2093 Q83930154-95926CF7-0A3E-47D2-BE0F-F1D344C7B032 @default.
- Q83930154 P2093 Q83930154-ADD62E46-B394-4E7D-8FAB-AFC7424C8BC9 @default.
- Q83930154 P2093 Q83930154-AF92EA44-DFBA-48A5-89BE-DB87A8646FEB @default.
- Q83930154 P2093 Q83930154-B6448FBF-B5AE-4119-8B04-8E9477070EE5 @default.
- Q83930154 P2093 Q83930154-BDB645E3-0ACA-4E1C-BF19-D684142D5730 @default.
- Q83930154 P2093 Q83930154-C17EB415-44CE-4EB8-948A-0A8905A3446C @default.
- Q83930154 P2093 Q83930154-D97465A3-52E7-4112-B5C0-3A42973F3D22 @default.
- Q83930154 P2093 Q83930154-EC552B50-088C-4953-B6D4-EDAF3F67BD09 @default.
- Q83930154 P2093 Q83930154-F82A22DD-4162-4C39-9DAB-0B61547BCBC9 @default.
- Q83930154 P304 Q83930154-756D75E3-46B4-4DE3-93A9-EB538FC3A82F @default.
- Q83930154 P31 Q83930154-57324F72-2D37-41D0-8619-6AC7C527AE95 @default.
- Q83930154 P356 Q83930154-32413429-CF2C-49D4-BF02-CB378FB51D6F @default.
- Q83930154 P433 Q83930154-32C683C5-4266-48CA-A65A-2AF417095B39 @default.
- Q83930154 P478 Q83930154-6F99CAA2-5830-4A98-A7B5-2EBF155B13F6 @default.
- Q83930154 P50 Q83930154-08F1EEFD-6C1F-4D7B-AAC2-CFAE2CE1D17A @default.
- Q83930154 P50 Q83930154-AA3FEFD1-8DC3-473E-A31F-5D55D70B34A0 @default.
- Q83930154 P50 Q83930154-E1B471EA-4714-4A64-BC49-0CCD637CAB75 @default.
- Q83930154 P577 Q83930154-473B2E6F-A8B0-4DAA-B9CD-E6724B138A63 @default.
- Q83930154 P698 Q83930154-180A23BE-3613-43F8-99E3-D9DD45075094 @default.
- Q83930154 P356 JCO.2005.05.2746 @default.
- Q83930154 P698 16754934 @default.
- Q83930154 P1433 Q400292 @default.
- Q83930154 P1476 "Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials" @default.
- Q83930154 P2093 "Anne-Marie Pény" @default.
- Q83930154 P2093 "Anton Hagenbeek" @default.
- Q83930154 P2093 "Berthe M P Aleman" @default.
- Q83930154 P2093 "Evert M Noordijk" @default.
- Q83930154 P2093 "Houchingue Eghbali" @default.
- Q83930154 P2093 "Jacques Bosq" @default.
- Q83930154 P2093 "John M M Raemaekers" @default.
- Q83930154 P2093 "José Thomas" @default.
- Q83930154 P2093 "Marjeta Vovk" @default.
- Q83930154 P2093 "Mathieu Monconduit" @default.
- Q83930154 P2093 "Noëlle Dupouy" @default.
- Q83930154 P2093 "Patrice Carde" @default.
- Q83930154 P2093 "Théodore Girinsky" @default.
- Q83930154 P2093 "Tom A M Verschueren" @default.
- Q83930154 P2093 "Umberto Tirelli" @default.
- Q83930154 P304 "3128-3135" @default.
- Q83930154 P31 Q13442814 @default.
- Q83930154 P356 "10.1200/JCO.2005.05.2746" @default.
- Q83930154 P433 "19" @default.
- Q83930154 P478 "24" @default.
- Q83930154 P50 Q45894648 @default.
- Q83930154 P50 Q50757186 @default.
- Q83930154 P50 Q57615296 @default.
- Q83930154 P577 "2006-06-05T00:00:00Z" @default.
- Q83930154 P698 "16754934" @default.